查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1634237

全球 Omega-3 補充品市場 - 2024 - 2031

Global Omega-3 Supplements Market - 2024 - 2031
出版日期: | 出版商: DataM Intelligence | 英文 176 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

概述

2023 年，全球 Omega-3 補充劑市場規模達到 72 億美元，預計到 2031 年將達到 141 億美元，2024-2031 年預測期間複合年成長率為 7.1%。

隨著消費者越來越意識到 EPA 和 DHA 等 omega-3 脂肪酸的健康益處，omega-3 補充劑市場正在經歷強勁成長，這些脂肪酸可支持心臟健康和大腦功能並減少發炎。隨著注重健康的消費者尋求預防性解決方案，對 omega-3 的需求持續成長，特別是由於心血管疾病的盛行率不斷上升和人口老化。

美國食品藥物管理局建議每天攝取膳食補充劑中 EPA 和 DHA 的總量不超過 5 克，這對於塑造 Omega-3 補充劑市場發揮著至關重要的作用。此外，植物性選擇的不斷增加，例如源自藻類的 omega-3，正在滿足純素食和環保意識的消費者的需求。隨著全球對健康的關注日益加深，omega-3 補充劑將在全球預防性健康策略中發揮重要作用。

美國成年人每天攝取 1.98 克 ALA，超過了建議攝取量，但 EPA 和 DHA 分別只有 35 毫克/天和 76 毫克/天，遠低於建議量。 EPA 和 DHA 攝取量的巨大差距支持了北美在全球 omega-3 補充劑市場的持續主導地位，因為消費者擴大轉向補充劑來滿足這些重要的營養需求。

動力學

提高消費者健康意識

由於消費者越來越認知到 omega-3 脂肪酸的健康益處，特別是對心臟健康、大腦功能和減少發炎的益處，該市場正在經歷快速成長。隨著越來越多的人關注預防性健康並尋求主動管理健康的方法，Omega-3 補充劑正在成為一種主食，支持市場的持續擴張。慢性病的盛行率不斷上升，特別是心血管問題和人口老化進一步刺激了需求。

補充劑消費進一步反映出天然健康解決方案日益成長的趨勢。根據負責任營養委員會的數據，2021 年Omega-3 等特種補充劑佔補充劑消費量的46%。 25% 飆升至70%。慢性病風險較高的人尤其推動了這個趨勢。

新的創新

omega-3 補充劑的創新對於推動全球市場的成長至關重要。提高 omega-3 脂肪酸生物利用度和吸收的技術進步正在滿足消費者對更有效、更方便的健康解決方案日益成長的需求。一個典型的例子是 Aker BioMarine 的 PL+ EPA/DHA 配方，與傳統魚油相比，該配方可顯著提高 EPA 和 DHA 的吸收 10.5 倍。

這款突破性配方結合了磷蝦磷脂和魚油，即使不需要脂肪餐，也能實現更好的消化和吸收。透過迎合越來越多的低脂飲食人群並提供更有效的補充劑，此類創新正在擴大市場範圍。隨著消費者的健康意識越來越強，尋求有科學根據、永續且高效的產品，PL+ 技術等創新正在加速市場成長。

高成本和永續性挑戰

優質 Omega-3 產品的高成本是全球 Omega-3 補充劑市場最重要的阻礙因素之一。優質 Omega-3 補充劑，特別是那些源自魚油的補充劑，由於萃取過程昂貴且需要高品質、濃縮的 EPA 和 DHA，因此生產成本通常較高。因此，這些產品的售價較高，對價格敏感的消費者難以負擔。

此外，對永續且符合道德來源的 Omega-3 的需求不斷成長，導致價格進一步上漲。過度捕撈的擔憂和環境永續發展的努力正在推動更好的採購實踐，例如使用負責任養殖的魚類或藻類油等植物性替代品。雖然這些替代品通常被認為更環保，但它們的生產成本可能更高，從而進一步推高價格。

目錄

第 1 章：方法與範圍

第 2 章：定義與概述

第 3 章：執行摘要

第 4 章：動力學

  • 影響因素
    • 促進要素
      • 提高消費者健康意識
      • 新的創新
    • 限制
      • 高成本和永續性挑戰
    • 機會
    • 影響分析

第 5 章：產業分析

  • 波特五力分析
  • 供應鏈分析
  • 定價分析
  • 監管分析
  • DMI 意見

第 6 章：按來源

  • 魚油
  • 磷蝦油
  • 海藻油
  • 其他

第 7 章：按形式

  • 軟膠囊
  • 液體
  • 粉末

第 8 章：按類型

  • 有機的
  • 傳統的

第 9 章：依功能分類

  • 心血管健康
  • 大腦與認知健康
  • 眼睛健康
  • 關節健康
  • 其他

第 10 章：按配銷通路

  • 超市/大賣場
  • 便利商店
  • 專賣店
  • 網路商店
  • 其他

第 11 章：最終用戶

  • 成年人
  • 孕婦
  • 孩子們
  • 老年
  • 其他

第 12 章：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 歐洲其他地區
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地區
  • 亞太
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 亞太其他地區
  • 中東和非洲

第13章：競爭格局

  • 競爭場景
  • 市場定位/佔有率分析
  • 併購分析

第 14 章：公司簡介

  • Nordic Naturals Inc
    • 公司概況
    • 產品組合和描述
    • 財務概覽
    • 主要進展
  • RB Health (US) LLC
  • Aker BioMarine Human Ingredients AS
  • dsm-firmenich
  • NOW Foods
  • Pharmavite LLC
  • Carlson Labs
  • The Coromega Company
  • NutriGold Inc
  • Barlean's Organic Oils, LLC

第 15 章：附錄

簡介目錄
Product Code: FB5089

Overview

Global Omega-3 Supplements Market reached US$ 7.2 billion in 2023 and is expected to reach US$ 14.1 billion by 2031, growing with a CAGR of 7.1 % during the forecast period 2024-2031.

The omega-3 supplements market is experiencing robust growth, driven by increasing consumer awareness of the health benefits of omega-3 fatty acids like EPA and DHA, which support heart health and brain function and reduce inflammation. As health-conscious consumers seek preventive solutions, demand for omega-3s continues to rise, particularly due to the growing prevalence of cardiovascular diseases and the aging population.

The US Food and Drug Administration's recommendation of consuming no more than 5 grams per day of EPA and DHA combined from dietary supplements plays a crucial role in shaping the Omega-3 supplements market. Additionally, the expanding availability of plant-based options, such as algae-derived omega-3s, is meeting the needs of vegan and environmentally-conscious consumers. As the global focus on wellness intensifies, omega-3 supplements are poised to remain vital to preventive health strategies worldwide.

American adults consume 1.98 grams/day of ALA, exceeding the recommended intake, but only 35 mg/day of EPA and 76 mg/day of DHA, well below recommended levels. This significant gap in EPA and DHA intake supports North America's continued dominance in the global omega-3 supplements market, as consumers increasingly turn to supplements to meet these vital nutritional needs.

Dynamics

Increasing Consumer Health Consciousness

The market is experiencing rapid growth, driven by rising consumer awareness of the health benefits of omega-3 fatty acids, particularly for heart health, brain function and inflammation reduction. As more people focus on preventive health and seeking ways to manage their health proactively, omega-3 supplements are becoming a staple, supporting the continued expansion of the market. The increasing prevalence of chronic diseases, especially cardiovascular issues and the aging population have further fueled demand.

Supplements consumption is further reflecting a growing trend toward natural health solutions. According to the Council for Responsible Nutrition, specialty supplements like Omega-3s accounted for 46% of supplement consumption in 2021. The market growth is also linked to the broader increase in dietary supplement use worldwide, which has surged from 25% to 70% over the past 40 years. Populations at higher risk for chronic conditions are particularly driving this trend.

New Innovations

Innovations in omega-3 supplementation are pivotal in driving the growth of the global market. Advances in technology that enhance the bioavailability and absorption of omega-3 fatty acids are meeting the increasing consumer demand for more effective and convenient health solutions. A prime example is Aker BioMarine's PL+ EPA/DHA formulation, which significantly boosts the absorption of EPA and DHA by 10.5 times compared to traditional fish oil.

The breakthrough formulation, which combines krill phospholipids and fish oil, allows for better digestion and absorption, even without needing a fatty meal. By catering to the growing number of individuals on low-fat diets and offering a more efficient supplement, such innovations are expanding the market's reach. As consumers become more health-conscious and seek scientifically-backed, sustainable and efficient products, innovations like PL+ technology are accelerating market growth.

High Costs and Sustainability Challenges

The high cost of quality Omega-3 products is one of the most significant hindering factors for the global Omega-3 supplements market. Premium Omega-3 supplements, particularly those derived from fish oil, often have higher production costs due to the expensive extraction processes and the need for high-quality, concentrated EPA and DHA. As a result, these products are sold at a premium price, making them less affordable for price-sensitive consumers.

Additionally, the growing demand for sustainable and ethically sourced Omega-3s has led to further price increases. Overfishing concerns and environmental sustainability efforts are pushing for better sourcing practices, such as using responsibly farmed fish or plant-based alternatives like algae oil. While these alternatives are often considered more eco-friendly, they can be costlier to produce, further driving up prices.

Segment Analysis

The global Omega-3 supplements market is segmented based on source, form, type, functionality, distribution channel, end-user and region.

High Concentration Of Essential Fatty Acids in Fish Oil

The global Omega-3 supplements market is segmented based on source into fish oil, krill oil, algae oil and others. The fish oil segment dominates the global omega-3 supplements market due to its high concentration of essential fatty acids, EPA and DHA, which are widely recognized for their health benefits, including improving heart health, reducing inflammation and supporting brain function. Fish oil is the most bioavailable and concentrated source of these Omega-3s, making it the preferred choice for consumers.

Extensive research and strong scientific evidence have built consumer trust in its efficacy, ensuring its position as the leading source of Omega-3 supplements. Additionally, fish oil is more cost-effective than alternatives like krill oil and algae oil, making it accessible to a larger consumer base, particularly in developing markets leading to new product launches adding to its dominance.

For instance the launch of NOW's Omega-3 Gummy Chews in August 2024. These sugar-free gummies provide 750 mg of fish oil with enhanced bioavailability, meeting strict purity and potency standards. Offering an affordable, high-quality health solution, they cater to consumers looking for convenient, effective Omega-3 supplementation. The product's availability both online and in select stores underscores the demand for accessible fish oil-based supplements.

Geographical Penetration

Increasing Health-Consciousness in North America

North America's dominance in the global omega-3 supplements market is supported by a well-established culture of health-consciousness, where supplements play a key role in daily wellness routines. According to the 2023 CRN Consumer Survey on Dietary Supplements, 74% of US adults take dietary supplements, with 55% considered regular users, highlighting Americans' mainstream acceptance of supplements.

The trend reflects a growing awareness of the health benefits of products like omega-3s, which are known to support heart health, reduce inflammation and improve brain function. The increasing reliance on supplements is driven by a preventive healthcare mindset, with many consumers seeking to enhance their overall well-being before health issues arise. Region's highly developed healthcare infrastructure and pharmaceutical companies continuously developing and promoting Omega-3 supplements.

Competitive Landscape

The major global players in the market include Nordic Naturals Inc, RB Health (US) LLC, Aker BioMarine Human Ingredients AS, dsm-firmenich, NOW Foods, Pharmavite LLC, Carlson Labs, The Coromega Company, NutriGold Inc and Barlean's Organic Oils, LLC.

Sustainability Analysis

The Omega-3 supplements market is growing rapidly, driven by rising demand for health benefits like improved heart health and brain function. However, the environmental impact of sourcing Omega-3, mainly from fish oil, raises concerns about overfishing. To address this, companies are adopting sustainable practices, such as sourcing from certified fisheries or using algae-based alternatives, to meet consumer demand for eco-friendly products.

As consumers increasingly prioritize ethical sourcing and transparency, brands are focusing on fair labor practices and responsible supply chains. Sustainability is also becoming a key competitive advantage, with many consumers willing to pay more for environmentally and socially responsible products. Balancing health benefits with sustainability is becoming crucial for the long-term success of the market.

Key Developments

  • In March 2024, Epax launched EPAX Omega 3-9-11, a concentrated oil combining omega-3s, omega-9 and omega-11 fatty acids. Using advanced EQP+ Tech, it targets skin health by improving barrier function and reducing inflammation, while offering broader metabolic benefits.
  • In January 2024, Ritual launched Omega-3 DHA + EPA, a vegan supplement with 500 mg of omega-3s in a 2:1 DHA to EPA ratio. Sourced sustainably from microalgae in France, it's designed for minimal burp-back with a natural citrus flavor. Third-party tested, gluten-free, soy-free and packaged in 100% recycled materials.

Why Purchase the Report?

  • To visualize the global Omega-3 supplements market segmentation based on source, form, type, functionality, distribution channel, end-user and region, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous Omega-3 supplements market-level data points with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as excel consisting of key products of all the major players.

The global omega-3 supplements market report would provide approximately 86 tables, 88 figures and 211 pages.

Target Audience 2024

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Source
  • 3.2. Snippet by Form
  • 3.3. Snippet by Type
  • 3.4. Snippet by Functionality
  • 3.5. Snippet by Distribution Channel
  • 3.6. Snippet by End-User
  • 3.7. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing Consumer Health Consciousness
      • 4.1.1.2. New Innovations
    • 4.1.2. Restraints
      • 4.1.2.1. High Costs and Sustainability Challenges
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. DMI Opinion

6. By Source

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
    • 6.1.2. Market Attractiveness Index, By Source
  • 6.2. Fish Oil
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Krill Oil
  • 6.4. Algae Oil
  • 6.5. Others

7. By Form

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 7.1.2. Market Attractiveness Index, By Form
  • 7.2. Soft Gel Capsules
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Liquid
  • 7.4. Powder

8. By Type

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 8.1.2. Market Attractiveness Index, By Type
  • 8.2. Organic
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Conventional

9. By Functionality

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Functionality
    • 9.1.2. Market Attractiveness Index, By Functionality
  • 9.2. Cardiovascular Health
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Brain & Cognitive Health
  • 9.4. Eye Health
  • 9.5. Joint Health
  • 9.6. Others

10. By Distribution Channel

  • 10.1. Introduction
  • 10.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
  • 10.3. Market Attractiveness Index, By Distribution Channel
  • 10.4. Supermarkets/Hypermarkets
    • 10.4.1. Introduction
    • 10.4.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 10.5. Convenience Stores
  • 10.6. Specialty Stores
  • 10.7. Online Stores
  • 10.8. Others

11. By End-User

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.1.2. Market Attractiveness Index, By End-User
  • 11.2. Adults
    • 11.2.1. Introduction
    • 11.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 11.3. Pregnant Women
  • 11.4. Children
  • 11.5. Elderly
  • 11.6. Others

12. By Region

  • 12.1. Introduction
    • 12.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 12.1.2. Market Attractiveness Index, By Region
  • 12.2. North America
    • 12.2.1. Introduction
    • 12.2.2. Key Region-Specific Dynamics
    • 12.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
    • 12.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 12.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 12.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Functionality
    • 12.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 12.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 12.2.9. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 12.2.10. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.2.10.1. US
      • 12.2.10.2. Canada
      • 12.2.10.3. Mexico
  • 12.3. Europe
    • 12.3.1. Introduction
    • 12.3.2. Key Region-Specific Dynamics
    • 12.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
    • 12.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 12.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 12.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Functionality
    • 12.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 12.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 12.3.9. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 12.3.10. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.3.10.1. Germany
      • 12.3.10.2. U.K.
      • 12.3.10.3. France
      • 12.3.10.4. Italy
      • 12.3.10.5. Spain
      • 12.3.10.6. Rest of Europe
  • 12.4. South America
    • 12.4.1. Introduction
    • 12.4.2. Key Region-Specific Dynamics
    • 12.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
    • 12.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 12.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 12.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Functionality
    • 12.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 12.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 12.4.9. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 12.4.10. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.4.10.1. Brazil
      • 12.4.10.2. Argentina
      • 12.4.10.3. Rest of South America
  • 12.5. Asia-Pacific
    • 12.5.1. Introduction
    • 12.5.2. Key Region-Specific Dynamics
    • 12.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
    • 12.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 12.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 12.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Functionality
    • 12.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 12.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 12.5.9. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 12.5.10. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.5.10.1. China
      • 12.5.10.2. India
      • 12.5.10.3. Japan
      • 12.5.10.4. Australia
      • 12.5.10.5. Rest of Asia-Pacific
  • 12.6. Middle East and Africa
    • 12.6.1. Introduction
    • 12.6.2. Key Region-Specific Dynamics
    • 12.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
    • 12.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 12.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 12.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Functionality
    • 12.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 12.6.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 12.6.9. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

13. Competitive Landscape

  • 13.1. Competitive Scenario
  • 13.2. Market Positioning/Share Analysis
  • 13.3. Mergers and Acquisitions Analysis

14. Company Profiles

  • 14.1. Nordic Naturals Inc
    • 14.1.1. Company Overview
    • 14.1.2. Product Portfolio and Description
    • 14.1.3. Financial Overview
    • 14.1.4. Key Developments
  • 14.2. RB Health (US) LLC
  • 14.3. Aker BioMarine Human Ingredients AS
  • 14.4. dsm-firmenich
  • 14.5. NOW Foods
  • 14.6. Pharmavite LLC
  • 14.7. Carlson Labs
  • 14.8. The Coromega Company
  • 14.9. NutriGold Inc
  • 14.10. Barlean's Organic Oils, LLC

LIST NOT EXHAUSTIVE

15. Appendix

  • 15.1. About Us and Services
  • 15.2. Contact Us